By InvitationNot Applicable

Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

United States100 participantsStarted 2022-06-01

Plain-language summary

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Has been seen at Stanford's Pain Management Center for a doctor's visit at least once. * Is scheduled to undergo at least 1 ketamine infusion for the treatment of any chronic pain condition. * Have a valid email address and consents to receiving surveys by email. * Able to read, understand, and respond to English-language surveys on an electronic device such as a cell phone, tablet, or computer. * Able to read, understand, and provide written, dated informed consent. Exclusion Criteria: * Has their ketamine infusion cancelled, which may occur before or after consenting to this study.

What they're measuring

Change from baseline Patient Global Impression of Change (PGIC) in overall status; measured with PGIC Scale

Timeframe: 1 week, 2 weeks, 1 month, 2 months, 3 months, 6 months, 12 months (or up to the time of their next ketamine infusion)

Trial details

NCT IDNCT05477004

SponsorTheresa Lii

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-12-31

View on ClinicalTrials.gov More Chronic Pain trials